Proceedings of the 19 th Otorhinolaryngology head and neck surgery national congress (PERHATIKL 2022)

<Previous Article In Volume
Next Article In Volume>

Allergic Rhinitis from Disease Discovery to Patient Management

Authors
Teti Madiadipoera1, *, Refika Padmis Sunaryo2
1Department of Otorhinolaryngology-Head and Neck Surgery, Faculty of Medicine, Universitas Padjadjaran, Dr Hasan Sadikin Hospital, Bandung, Indonesia
2Faculty of Medicine, Universitas Padjadjaran, Bandung, Indonesia
*Corresponding author.
Corresponding Author
Teti Madiadipoera
Available Online 31 October 2023.
DOI
10.2991/978-94-6463-280-4_2How to use a DOI?
Keywords
allergic rhinitis; nasal irrigation; rupatadine; anti platelet-activating factor (PAF); Quality of Life
Abstract

Allergic rhinitis (AR) is a clinically defined disorder of the nose characterized by symptoms triggered by allergen exposure, leading to an IgE-mediated inflammation. It is a global health problem affecting up to 50% of the world's population, with symptoms extending beyond nasal obstruction, rhinorrhea, sneezing, and itching, impacting productivity, school performance, sleep, and quality of life (QoL). Untreated AR can result in multimorbidity, linking with conditions such as asthma, rhinosinusitis, adenoid hypertrophy, otitis media, dysphonia, laryngopharyngeal reflux, OSA, and migraine. ARIA classifies AR into intermittent or persistent and mild or moderate-severe, recommending management approaches including allergen avoidance, antihistamines, intranasal steroids, immunotherapy, and surgical interventions. This presentation focuses on nasal irrigation and rupatadine, a non-sedating antihistamine with antiplatelet activating factor properties, aiming to improve QoL and safety for AR patients.

Copyright
© 2023 The Author(s)
Open Access
Open Access This chapter is licensed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which permits any noncommercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license and indicate if changes were made.

Download article (PDF)

<Previous Article In Volume
Next Article In Volume>
Volume Title
Proceedings of the 19 th Otorhinolaryngology head and neck surgery national congress (PERHATIKL 2022)
Series
Advances in Health Sciences Research
Publication Date
31 October 2023
ISBN
10.2991/978-94-6463-280-4_2
ISSN
2468-5739
DOI
10.2991/978-94-6463-280-4_2How to use a DOI?
Copyright
© 2023 The Author(s)
Open Access
Open Access This chapter is licensed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which permits any noncommercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license and indicate if changes were made.

Cite this article

risenwbib
TY  - CONF
AU  - Teti Madiadipoera
AU  - Refika Padmis Sunaryo
PY  - 2023
DA  - 2023/10/31
TI  - Allergic Rhinitis from Disease Discovery to Patient Management
BT  - Proceedings of the 19 th Otorhinolaryngology head and neck surgery national congress (PERHATIKL 2022)
PB  - Atlantis Press
SP  - 5
EP  - 10
SN  - 2468-5739
UR  - https://doi.org/10.2991/978-94-6463-280-4_2
DO  - 10.2991/978-94-6463-280-4_2
ID  - Madiadipoera2023
ER  -